Rennova Health Inc
(RNVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 929 | -651 | 1,339 | 1,951 | 2,069 |
| Cost of Goods | 1,269 | 1,597 | 3,632 | 2,806 | 2,669 |
| Gross Profit | -341 | -2,248 | -2,293 | -855 | -600 |
| Operating Expenses | 2,569 | 3,573 | 4,238 | 4,134 | 3,250 |
| Operating Income | -2,640 | -5,224 | -5,898 | -4,183 | -3,181 |
| Interest Expense | 890 | 913 | 1,914 | 2,378 | 2,659 |
| Other Income | 2,040 | 2,469 | -338 | 535 | 7,993 |
| Pre-tax Income | -1,490 | -3,667 | -8,150 | -6,026 | 2,153 |
| Income Tax | N/A | N/A | -190 | N/A | N/A |
| Net Income Continuous | -1,490 | -3,667 | -7,961 | -6,026 | 2,153 |
| Net Income Discontinuous | 10,561 | -227 | -517 | -166 | -32 |
| Net Income | $9,071 | $-3,894 | $-8,478 | $-6,192 | $2,122 |
| EPS Basic Total Ops | -123,368.00 | -2,170,086.00 | 60,969.84 | -54,312.31 | -1,039.13 |
| EPS Basic Continuous Ops | -137,815.90 | -2,161,019.00 | 60,829.07 | -54,182.89 | -1,007.08 |
| EPS Basic Discontinuous Ops | 14,447.90 | -9,066.64 | 140.77 | -129.42 | -32.05 |
| EPS Diluted Total Ops | -123,368.00 | -2,170,086.00 | 60,969.84 | -54,312.31 | -1,039.13 |
| EPS Diluted Continuous Ops | -137,815.90 | -2,161,019.00 | 60,829.07 | -54,182.89 | -1,007.08 |
| EPS Diluted Discontinuous Ops | 14,447.90 | -9,066.64 | 140.77 | -129.42 | -32.05 |
| EBITDA(a) | $-2,424 | $-5,034 | $-5,583 | $-4,084 | $-2,954 |